Mateja Kaja Jezovnik Selected Research

Mateja Kaja Jezovnik Research Topics

3	Inflammation (Inflammations) 01/2020 - 04/2014
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 11/2010
2	Thrombosis (Thrombus) 01/2020 - 04/2015
2	Venous Thromboembolism 01/2018 - 11/2011
2	Pathologic Constriction (Stenosis) 01/2017 - 04/2014
1	Obesity 01/2023
1	Pulmonary Embolism 01/2018
1	Hemorrhage 01/2018
1	Rupture 01/2018
1	Atherosclerotic Plaque (Atheroma) 01/2017
1	Intermittent Claudication 06/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2015
1	Dyslipidemias (Dyslipidemia) 11/2011

2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2015 - 11/2011
1	Plasminogen Activator Inhibitor 1IBA 01/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Thromboplastin (Tissue Factor)IBA 01/2020
1	apixabanIBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018
1	Warfarin (Coumadin)FDA LinkGeneric 01/2018
1	LipidsIBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 06/2015
1	AngiotensinsIBA 06/2015
1	AnticoagulantsIBA 04/2015
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2015
1	Indicators and Reagents (Reagents)IBA 04/2014
1	CytokinesIBA 11/2011
1	Interleukin-10 (Interleukin 10)IBA 11/2011
1	Nitroglycerin (Dynamite)FDA LinkGeneric 11/2010

2	Endarterectomy (Thromboendarterectomy) 01/2017 - 04/2014
1	Drug Therapy (Chemotherapy) 01/2023